TBNHealth
STAT+: Up and down the ladder: The latest comings and goings
Publication: STAT
Author: Ed Silverman
Source published: 09/10/2026, 13:59:35 UTC
Briefing created: 09/10/2026, 15:30:02 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 09/10/2026, 14:06:24 UTC.
Briefings
STAT+ reported that Q32 Bio hired José Trevejo as chief medical officer in October 2026. Trevejo previously served as chief medical officer and head of clinical pipeline strategy at Enveda Therapeutics. The article highlights that the role requires dynamic leadership, contrasting with the static nature of the position. Coverage is limited to the specific hiring announcement and does not include details about the company's current operations or Trevejo's performance metrics.
Key points
- Q32 Bio hired José Trevejo as chief medical officer in October 2026.
- Trevejo previously held the same role at Enveda Therapeutics.
Context and limitations
This briefing covers only the specific hiring announcement and prior employment history. It does not include information about Q32 Bio's current operations, Trevejo's performance metrics, or the company's strategic direction.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 09/10/2026, 15:30:02 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeicn5jbb7ays3kkfemu456y55mzktafbhhym6qwcsaggo66dl6tl7u